"Restrictive" fluid management is usually the current standard practice for patients undergoing liver surgery. The general idea is to maintain a low central venous pressure in order to decrease blood loss and improve the quality of the surgical field. However, this strategy , considered as rather "restrictive", can be associated with patient's harm, mainly acute kidney injury. Today, Goal directed fluid therapy (GDFT) is a well accepted strategy to optimize fluid administration in patients undergoing major surgery which aimed to maintain normovolemia without being too liberal. The goal of this randomized controlled trial is to compare these two strategies on Urethral Perfusion index measured with a new IKORUS UP probe (Foley catheter made smarter with embedded photoplethysmographic sensing technology).
Restrictive fluid administration aiming at maintaining a low central venous pressure (low-CVP) during liver surgery has always been considered as a "gold standard" strategy because it decrease blood loss and improve the quality of the surgical field. However, this strategy , rather "restrictive", can be associated with patient harm (mainly AKI). Today, Goal directed fluid therapy (GDFT) is a well accepted strategy to optimize fluid administration in patients undergoing major surgery.Some studies have shown that this strategy is feasible for such patient population. There is currently a lack of data supporting the advantage of one strategy over the other in this patient population.While a restrictive fluid strategy can advantage the surgeon, it can also disadvantage the patient as in order to avoid hypotension, vasopressors administration is required. If the patient is hypovolemic, such strategy may cause acute kidney injury. The goal of this randomized controlled trial is to compare these two strategies on Urethral Perfusion index measured with a new Foley catheter with embedded photoplethysmographic sensing technology). This new technology allows for continuous and easy monitoring of urethral tissue perfusion The investigators hypothesis is that patients in the GDFT group will have better Urethral Perfusion index (uPI) during surgery (via a better cardiac blood flow optimization) compared to patients in the restrictive (low CVP) group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
The titration of fluid will be based on stroke volume variation. The goal is to maintain this variable \< 13% during surgery with multiple mini fluid challenge of 100 ml of balanced crystalloid.
Goal = CVP \< 7mmHg and only 2 ml/kg/h max during surgery.
Erasme Hospital
Brussels, Brussel-hoofdstad, Belgium
Urethral Perfusion index
average of the Urethral Perfusion index values
Time frame: during surgery
Urethral Perfusion index
average of the Urethral Perfusion index values during the first 15-30 minutes of the surgery
Time frame: during surgery
Urethral Perfusion index
average of the Urethral Perfusion index values during the last 15-30 minutes of the surgery
Time frame: during surgery
Amount of fluid during surgery
amount of crystalloid received during the surgery
Time frame: during surgery
Amount of vasopressors
amount of vasopressors received during surgery
Time frame: during surgery
Stroke volume index
average of stroke volume index during surgery
Time frame: during surgery
stroke volume variation
average of stroke volume variation during surgery
Time frame: during surgery
cardiac index
average of cardiac index during surgery
Time frame: during surgery
incidence of acute kidney injury
incidence of acute kidney injury measured with the KDIGO classification
Time frame: At postoperative day 7
length of stay in the hospital
length of stay in the hospital
Time frame: Postoperative day 30
Incidence of postoperative complications
Incidence of postoperative complications
Time frame: Postoperative day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.